Plavix Disclosures are Probed

The U.S. Justice Department is investigating disclosures to the FDA about the variability in patient responses to the blood-thinning drug Plavix, according to Sanofi, one of the drug's co-marketers.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news